AST 0 3 0 3 B-clinical_variable
or 4 6 4 6 I-clinical_variable
ALT 7 10 7 10 I-clinical_variable
> 11 12 11 12 O
3 13 14 13 14 B-lower_bound
times 15 20 15 20 I-lower_bound
the 21 24 21 24 I-lower_bound
upper 25 30 25 30 I-lower_bound
limit 31 36 31 36 I-lower_bound
of 37 39 37 39 I-lower_bound
normal 40 46 40 46 I-lower_bound

Able 0 4 47 51 O
to 5 7 52 54 O
start 8 13 55 60 O
bevacizumab 14 25 61 72 B-treatment
at 26 28 73 75 O
least 29 34 76 81 O
2 35 36 82 83 B-lower_bound
weeks 37 42 84 89 I-lower_bound
but 43 46 90 93 O
no 47 49 94 96 O
more 50 54 97 101 O
than 55 59 102 106 O
4 60 61 107 108 B-upper_bound
weeks 62 67 109 114 I-upper_bound
from 68 72 115 119 O
date 73 77 120 124 O
of 78 80 125 127 O
biopsy 81 87 128 134 O

Adequate 0 8 135 143 O
coagulation 9 20 144 155 O
defined 21 28 156 163 O
as 29 31 164 166 O
PT 32 34 167 169 B-clinical_variable
and 35 38 170 173 O
INR 39 42 174 177 B-clinical_variable
< 43 44 178 179 O
1.5 45 48 180 183 B-upper_bound
times 49 54 184 189 I-upper_bound
the 55 58 190 193 O
upper 59 64 194 199 B-clinical_variable
limit 65 70 200 205 I-clinical_variable
of 71 73 206 208 I-clinical_variable
normal 74 80 209 215 I-clinical_variable

Any 0 3 216 219 O
other 4 9 220 225 O
malignancy 10 20 226 236 B-cancer

At 0 2 237 239 O
least 3 8 240 245 O
22 9 11 246 248 B-lower_bound
years 12 17 249 254 I-lower_bound
of 18 20 255 257 O
age 21 24 258 261 B-age

Baseline 0 8 262 270 O
hemoglobin 9 19 271 281 B-clinical_variable
of 20 22 282 284 O
> 23 24 285 286 O
8.0 25 28 287 290 B-lower_bound
gm 29 31 291 293 I-lower_bound
/ 31 32 293 294 I-lower_bound
dL 32 34 294 296 I-lower_bound
( 35 36 297 298 O
with 36 40 298 302 O
or 41 43 303 305 O
without 44 51 306 313 O
transfusion 52 63 314 325 O
) 63 64 325 326 O

Core 0 4 327 331 B-treatment
biopsy 5 11 332 338 I-treatment
or 12 14 339 341 O
other 15 20 342 347 O
minor 21 26 348 353 B-treatment
surgical 27 35 354 362 I-treatment
procedure 36 45 363 372 I-treatment
, 45 46 372 373 O
excluding 47 56 374 383 O
placement 57 66 384 393 B-treatment
of 67 69 394 396 I-treatment
a 70 71 397 398 I-treatment
vascular 72 80 399 407 I-treatment
access 81 87 408 414 I-treatment
device 88 94 415 421 I-treatment
, 94 95 421 422 O
within 96 102 423 429 O
7 103 104 430 431 B-upper_bound
days 105 109 432 436 I-upper_bound
prior 110 115 437 442 I-upper_bound
to 116 118 443 445 O
study 119 124 446 451 O
enrollment 125 135 452 462 O

Currently 0 9 463 472 O
taking 10 16 473 479 O
anticoagulants 17 31 480 494 B-treatment
or 32 34 495 497 O
blood 35 40 498 503 B-treatment
- 40 41 503 504 I-treatment
thinners 41 49 504 512 I-treatment
( 50 51 513 514 I-treatment
Coumadin 51 59 514 522 I-treatment
) 59 60 522 523 I-treatment

Currently 0 9 524 533 O
taking 10 16 534 540 O
cytotoxic 17 26 541 550 B-treatment
medications 27 38 551 562 I-treatment
, 38 39 562 563 O
non 40 43 564 567 B-treatment
- 43 44 567 568 I-treatment
steroidal 44 53 568 577 I-treatment
ant 54 57 578 581 I-treatment
- 57 58 581 582 I-treatment
inflammatory 58 70 582 594 I-treatment
drugs 71 76 595 600 I-treatment
( 77 78 601 602 I-treatment
NSAIDS 78 84 602 608 I-treatment
) 84 85 608 609 I-treatment
, 85 86 609 610 O
or 87 89 611 613 O
enzyme 90 96 614 620 B-treatment
inducing 97 105 621 629 I-treatment
anticonvulsants 106 121 630 645 I-treatment

Evidence 0 8 646 654 O
of 9 11 655 657 O
bleeding 12 20 658 666 B-chronic_disease
diathesis 21 30 667 676 I-chronic_disease
or 31 33 677 679 O
coagulopathy 34 46 680 692 B-chronic_disease
( 47 48 693 694 O
in 48 50 694 696 O
the 51 54 697 700 O
absence 55 62 701 708 O
of 63 65 709 711 O
therapeutic 66 77 712 723 B-treatment
anticoagulation 78 93 724 739 I-treatment
) 93 94 739 740 O

Have 0 4 741 745 O
undergone 5 14 746 755 O
a 15 16 756 757 O
brain 17 22 758 763 B-treatment
biopsy 23 29 764 770 I-treatment
via 30 33 771 774 O
stereotactic 34 46 775 787 O
or 47 49 788 790 O
open 50 54 791 795 O
technique 55 64 796 805 O

History 0 7 806 813 O
of 8 10 814 816 O
abdominal 11 20 817 826 B-chronic_disease
fistula 21 28 827 834 I-chronic_disease
, 28 29 834 835 O
gastrointestinal 30 46 836 852 B-clinical_variable
perforation 47 58 853 864 I-clinical_variable
within 59 65 865 871 O
6 66 67 872 873 B-upper_bound
months 68 74 874 880 I-upper_bound
prior 75 80 881 886 I-upper_bound
to 81 83 887 889 O
study 84 89 890 895 O
enrollment 90 100 896 906 O

History 0 7 907 914 O
of 8 10 915 917 O
hemoptysis 11 21 918 928 B-chronic_disease
( 22 23 929 930 O
greater 23 30 930 937 O
than 31 35 938 942 O
or 36 38 943 945 O
equal 39 44 946 951 O
to 45 47 952 954 O
a 48 49 955 956 O
half 50 54 957 961 O
teaspoon 55 63 962 970 O
of 64 66 971 973 O
bright 67 73 974 980 O
red 74 77 981 984 O
blood 78 83 985 990 O
per 84 87 991 994 O
episode 88 95 995 1002 O
) 95 96 1002 1003 O
within 97 103 1004 1010 O
1 104 105 1011 1012 B-upper_bound
month 106 111 1013 1018 I-upper_bound
prior 112 117 1019 1024 I-upper_bound
to 118 120 1025 1027 O
study 121 126 1028 1033 O
enrollment 127 137 1034 1044 O

History 0 7 1045 1052 O
of 8 10 1053 1055 O
hypersensitivity 11 27 1056 1072 O
reaction 28 36 1073 1081 O
to 37 39 1082 1084 O
temozolomide 40 52 1085 1097 B-allergy_name
or 53 55 1098 1100 O
a 56 57 1101 1102 O
history 58 65 1103 1110 O
of 66 68 1111 1113 O
hypersensitivity 69 85 1114 1130 O
to 86 88 1131 1133 O
DTIC 89 93 1134 1138 B-allergy_name
or 94 96 1139 1141 O
hydrogel 97 105 1142 1150 B-allergy_name

History 0 7 1151 1158 O
of 8 10 1159 1161 O
myocardial 11 21 1162 1172 B-chronic_disease
infarction 22 32 1173 1183 I-chronic_disease
or 33 35 1184 1186 O
unstable 36 44 1187 1195 B-chronic_disease
angina 45 51 1196 1202 I-chronic_disease
within 52 58 1203 1209 O
6 59 60 1210 1211 B-upper_bound
months 61 67 1212 1218 I-upper_bound
prior 68 73 1219 1224 I-upper_bound
to 74 76 1225 1227 O
study 77 82 1228 1233 O
enrollment 83 93 1234 1244 O

History 0 7 1245 1252 O
of 8 10 1253 1255 O
stroke 11 17 1256 1262 B-chronic_disease
or 18 20 1263 1265 O
transient 21 30 1266 1275 B-chronic_disease
ischemic 31 39 1276 1284 I-chronic_disease
attack 40 46 1285 1291 I-chronic_disease
within 47 53 1292 1298 O
6 54 55 1299 1300 B-upper_bound
months 56 62 1301 1307 I-upper_bound
prior 63 68 1308 1313 I-upper_bound
to 69 71 1314 1316 O
study 72 77 1317 1322 O
enrollment 78 88 1323 1333 O

Implanted 0 9 1334 1343 B-treatment
pacemaker 10 19 1344 1353 I-treatment

Inability 0 9 1354 1363 O
to 10 12 1364 1366 O
adequately 13 23 1367 1377 O
cover 24 29 1378 1383 O
treatment 30 39 1384 1393 O
area 40 44 1394 1398 O
with 45 49 1399 1403 O
TTFields 50 58 1404 1412 B-treatment
( 59 60 1413 1414 I-treatment
Tumor 60 65 1414 1419 I-treatment
Treating 66 74 1420 1428 I-treatment
Fields 75 81 1429 1435 I-treatment
) 81 82 1435 1436 I-treatment

Inability 0 9 1437 1446 O
to 10 12 1447 1449 O
wear 13 17 1450 1454 O
NovoTTF-100A 18 30 1455 1467 B-treatment
System 31 37 1468 1474 I-treatment
for 38 41 1475 1478 O
an 42 44 1479 1481 O
average 45 52 1482 1489 O
of 53 55 1490 1492 O
18 56 58 1493 1495 B-upper_bound
hours 59 64 1496 1501 I-upper_bound
per 65 68 1502 1505 O
24 69 71 1506 1508 O
hours 72 77 1509 1514 O

Inadequately 0 12 1515 1527 O
controlled 13 23 1528 1538 O
hypertension 24 36 1539 1551 B-chronic_disease

Infra 0 5 1552 1557 B-cancer
- 5 6 1557 1558 I-cancer
tentorial 6 15 1558 1567 I-cancer
tumor 16 21 1568 1573 I-cancer

Karnofsky 0 9 1574 1583 B-clinical_variable
scale 10 15 1584 1589 I-clinical_variable
greater 16 23 1590 1597 O
than 24 28 1598 1602 O
or 29 31 1603 1605 O
equal 32 37 1606 1611 O
to 38 40 1612 1614 O
70 41 43 1615 1617 B-lower_bound

Known 0 5 1618 1623 O
hypersensitivity 6 22 1624 1640 O
to 23 25 1641 1643 O
any 26 29 1644 1647 O
component 30 39 1648 1657 O
of 40 42 1658 1660 O
bevacizumab 43 54 1661 1672 B-allergy_name

Life 0 4 1673 1677 B-clinical_variable
expectancy 5 15 1678 1688 I-clinical_variable
at 16 18 1689 1691 O
least 19 24 1692 1697 O
3 25 26 1698 1699 B-lower_bound
months 27 33 1700 1706 I-lower_bound

Major 0 5 1707 1712 B-treatment
surgical 6 14 1713 1721 I-treatment
procedure 15 24 1722 1731 O
or 25 27 1732 1734 O
significant 28 39 1735 1746 O
traumatic 40 49 1747 1756 O
injury 50 56 1757 1763 O
within 57 63 1764 1770 O
28 64 66 1771 1773 B-upper_bound
days 67 71 1774 1778 I-upper_bound
prior 72 77 1779 1784 I-upper_bound
to 78 80 1785 1787 O
1st 81 84 1788 1791 O
bevacizumab 85 96 1792 1803 B-treatment
infusion 97 105 1804 1812 O
or 106 108 1813 1815 O
anticipation 109 121 1816 1828 O
of 122 124 1829 1831 O
need 125 129 1832 1836 O
for 130 133 1837 1840 O
major 134 139 1841 1846 B-treatment
surgical 140 148 1847 1855 I-treatment
procedure 149 158 1856 1865 O
during 159 165 1866 1872 O
the 166 169 1873 1876 O
course 170 176 1877 1883 O
of 177 179 1884 1886 O
the 180 183 1887 1890 O
study 184 189 1891 1896 O

Neutropenia 0 11 1897 1908 B-chronic_disease
( 12 13 1909 1910 O
absolute 13 21 1910 1918 B-clinical_variable
neutrophil 22 32 1919 1929 I-clinical_variable
count 33 38 1930 1935 I-clinical_variable
< 39 40 1936 1937 O
1.5 41 44 1938 1941 B-upper_bound
x 45 46 1942 1943 I-upper_bound
103 47 50 1944 1947 I-upper_bound
) 51 52 1948 1949 O

New 0 3 1950 1953 O
York 4 8 1954 1958 O
Heart 9 14 1959 1964 O
Association 15 26 1965 1976 O
( 27 28 1977 1978 O
NYHA 28 32 1978 1982 O
) 32 33 1982 1983 O
Grade 34 39 1984 1989 B-lower_bound
II 40 42 1990 1992 I-lower_bound
or 43 45 1993 1995 O
greater 46 53 1996 2003 O
congestive 54 64 2004 2014 B-chronic_disease
heart 65 70 2015 2020 I-chronic_disease
failure 71 78 2021 2028 I-chronic_disease

Participants 0 12 2029 2041 O
of 13 15 2042 2044 O
childbearing 16 28 2045 2057 O
age 29 32 2058 2061 B-age
must 33 37 2062 2066 O
use 38 41 2067 2070 B-contraception_consent
effective 42 51 2071 2080 I-contraception_consent
contraception 52 65 2081 2094 I-contraception_consent
for 66 69 2095 2098 O
at 70 72 2099 2101 O
least 73 78 2102 2107 O
6 79 80 2108 2109 B-lower_bound
months 81 87 2110 2116 I-lower_bound
following 88 97 2117 2126 O
completion 98 108 2127 2137 O
of 109 111 2138 2140 O
treatment 112 121 2141 2150 B-treatment

Pathological 0 12 2151 2163 O
evidence 13 21 2164 2172 O
of 22 24 2173 2175 O
GBM 25 28 2176 2179 B-cancer
using 29 34 2180 2185 O
WHO 35 38 2186 2189 O
classification 39 53 2190 2204 O
criteria 54 62 2205 2213 O

Planned 0 7 2214 2221 O
6 8 9 2222 2223 O
weeks 10 15 2224 2229 O
of 16 18 2230 2232 O
concurrent 19 29 2233 2243 B-treatment
chemoradiotherapy 30 47 2244 2261 I-treatment
post 48 52 2262 2266 O
- 52 53 2266 2267 O
biopsy 53 59 2267 2273 O
concomitant 60 71 2274 2285 O
with 72 76 2286 2290 O
temozolomide 77 89 2291 2303 B-treatment
( 90 91 2304 2305 O
45 91 93 2305 2307 B-lower_bound
- 93 94 2307 2308 O
70Gy 94 98 2308 2312 B-upper_bound
) 98 99 2312 2313 O

Pregnant 0 8 2314 2322 B-pregnancy

Prior 0 5 2323 2328 O
history 6 13 2329 2336 O
of 14 16 2337 2339 O
hypertensive 17 29 2340 2352 B-chronic_disease
crisis 30 36 2353 2359 I-chronic_disease
or 37 39 2360 2362 O
hypertensive 40 52 2363 2375 B-chronic_disease
encephalopathy 53 67 2376 2390 I-chronic_disease

Proteinuria 0 11 2391 2402 B-chronic_disease
at 12 14 2403 2405 O
screening 15 24 2406 2415 O

Serious 0 7 2416 2423 O
, 7 8 2423 2424 O
non 9 12 2425 2428 B-chronic_disease
- 12 13 2428 2429 I-chronic_disease
healing 13 20 2429 2436 I-chronic_disease
wound 21 26 2437 2442 I-chronic_disease
, 26 27 2442 2443 O
active 28 34 2444 2450 O
ulcer 35 40 2451 2456 B-chronic_disease
, 40 41 2456 2457 O
or 42 44 2458 2460 O
untreated 45 54 2461 2470 O
bone 55 59 2471 2475 B-chronic_disease
fracture 60 68 2476 2484 I-chronic_disease

Significant 0 11 2485 2496 O
co 12 14 2497 2499 O
- 14 15 2499 2500 O
morbidities 15 26 2500 2511 O
at 27 29 2512 2514 O
baseline 30 38 2515 2523 O
which 39 44 2524 2529 O
would 45 50 2530 2535 O
prevent 51 58 2536 2543 O
maintenance 59 70 2544 2555 O
temozolomide 71 83 2556 2568 B-treatment

Significant 0 11 2569 2580 O
liver 12 17 2581 2586 B-chronic_disease
function 18 26 2587 2595 I-chronic_disease
impairment 27 37 2596 2606 I-chronic_disease

Significant 0 11 2607 2618 O
renal 12 17 2619 2624 B-chronic_disease
impairment 18 28 2625 2635 I-chronic_disease
( 29 30 2636 2637 O
serum 30 35 2637 2642 B-clinical_variable
creatinine 36 46 2643 2653 I-clinical_variable
> 46 47 2653 2654 O
1.7 48 51 2655 2658 B-lower_bound
mg 52 54 2659 2661 I-lower_bound
/ 54 55 2661 2662 I-lower_bound
dL 55 57 2662 2664 I-lower_bound
) 57 58 2664 2665 O

Significant 0 11 2666 2677 O
vascular 12 20 2678 2686 B-chronic_disease
disease 21 28 2687 2694 I-chronic_disease
( 29 30 2695 2696 O
e.g. 30 34 2696 2700 O
, 34 35 2700 2701 O
aortic 36 42 2702 2708 B-chronic_disease
aneurysm 43 51 2709 2717 I-chronic_disease
, 51 52 2717 2718 O
requiring 53 62 2719 2728 O
surgical 63 71 2729 2737 O
repair 72 78 2738 2744 O
or 79 81 2745 2747 O
recent 82 88 2748 2754 O
peripheral 89 99 2755 2765 O
arterial 100 108 2766 2774 O
thrombosis 109 119 2775 2785 O
) 119 120 2785 2786 O
within 121 127 2787 2793 O
6 128 129 2794 2795 B-upper_bound
months 130 136 2796 2802 I-upper_bound
prior 137 142 2803 2808 I-upper_bound
to 143 145 2809 2811 O
study 146 151 2812 2817 O
enrollment 152 162 2818 2828 O

Subjects 0 8 2829 2837 O
meeting 9 16 2838 2845 O
any 17 20 2846 2849 O
of 21 23 2850 2852 O
the 24 27 2853 2856 O
following 28 37 2857 2866 O
bevacizumab 38 49 2867 2878 B-allergy_name
- 49 50 2878 2879 O
specific 50 58 2879 2887 O
contraindications 59 76 2888 2905 O

Thrombocytopenia 0 16 2906 2922 B-chronic_disease
( 17 18 2923 2924 O
platelet 18 26 2924 2932 B-clinical_variable
count 27 32 2933 2938 I-clinical_variable
< 33 34 2939 2940 O
100 35 38 2941 2944 B-upper_bound
x 39 40 2945 2946 I-upper_bound
103 41 44 2947 2950 I-upper_bound
) 45 46 2951 2952 O

Total 0 5 2953 2958 O
bilirubin 6 15 2959 2968 B-clinical_variable
> 15 16 2968 2969 O
2 17 18 2970 2971 B-lower_bound
times 19 24 2972 2977 I-lower_bound
the 25 28 2978 2981 I-lower_bound
upper 29 34 2982 2987 I-lower_bound
limit 35 40 2988 2993 I-lower_bound
of 41 43 2994 2996 I-lower_bound
normal 44 50 2997 3003 I-lower_bound

alopecia 0 8 3004 3012 B-chronic_disease

clinically 0 10 3013 3023 O
significant 11 22 3024 3035 O
papilledema 23 34 3036 3047 B-chronic_disease

creatinine 0 10 3048 3058 B-clinical_variable
( 11 12 3059 3060 I-clinical_variable
UPC 12 15 3060 3063 I-clinical_variable
) 15 16 3063 3064 I-clinical_variable
ratio 17 22 3065 3070 I-clinical_variable
greater 23 30 3071 3078 O
than 31 35 3079 3083 O
or 36 38 3084 3086 O
equal 39 44 3087 3092 O
to 45 47 3093 3095 O
1.0 48 51 3096 3099 B-lower_bound
at 52 54 3100 3102 O
screening 55 64 3103 3112 O

deep 0 4 3113 3117 B-treatment
brain 5 10 3118 3123 I-treatment
stimulator 11 21 3124 3134 I-treatment

defibrillator 0 13 3135 3148 B-treatment

diastolic 0 9 3149 3158 B-clinical_variable
blood 10 15 3159 3164 I-clinical_variable
pressure 16 24 3165 3173 I-clinical_variable
> 25 26 3174 3175 O
100 27 30 3176 3179 B-lower_bound
mmHg 31 35 3180 3184 I-lower_bound

documented 0 10 3185 3195 O
clinically 11 21 3196 3206 O
significant 22 33 3207 3218 O
arrhythmias 34 45 3219 3230 B-chronic_disease

localized 0 9 3231 3240 O
basal 10 15 3241 3246 B-cancer
cell 16 20 3247 3251 I-cancer

midline 0 7 3252 3259 B-clinical_variable
shift 8 13 3260 3265 I-clinical_variable
> 14 15 3266 3267 O
5 16 17 3268 3269 B-lower_bound
mm 17 19 3269 3271 I-lower_bound

nausea 0 6 3272 3278 B-chronic_disease

patients 0 8 3279 3287 O
discovered 9 19 3288 3298 O
to 20 22 3299 3301 O
have 23 27 3302 3306 O
greater 28 35 3307 3314 O
than 36 40 3315 3319 O
or 41 43 3320 3322 O
equal 44 49 3323 3328 O
to 50 52 3329 3331 O
2 53 54 3332 3333 B-lower_bound
or 55 57 3334 3336 O
greater 58 65 3337 3344 O
proteinuria 66 77 3345 3356 B-clinical_variable
on 78 80 3357 3359 O
dipstick 81 89 3360 3368 B-treatment
urinalysis 90 100 3369 3379 I-treatment
at 101 103 3380 3382 O
baseline 104 112 3383 3391 O
should 113 119 3392 3398 O
undergo 120 127 3399 3406 O
a 128 129 3407 3408 O
24 130 132 3409 3411 B-upper_bound
- 132 133 3411 3412 O
hour 133 137 3412 3416 O
urine 138 143 3417 3422 O
collection 144 154 3423 3433 O
and 155 158 3434 3437 O
must 159 163 3438 3442 O
demonstrate 164 175 3443 3454 O
less 176 180 3455 3459 O
than 181 185 3460 3464 O
or 186 188 3465 3467 O
equal 189 194 3468 3473 O
to 195 197 3474 3476 O
1 198 199 3477 3478 B-upper_bound
g 199 200 3478 3479 I-upper_bound
of 201 203 3480 3482 O
protein 204 211 3483 3490 O
in 212 214 3491 3493 O
24 215 217 3494 3496 O
hours 218 223 3497 3502 O

squamous 0 8 3503 3511 B-cancer
cell 9 13 3512 3516 I-cancer
carcinoma 14 23 3517 3526 I-cancer
of 24 26 3527 3529 I-cancer
the 27 30 3530 3533 I-cancer
skin 31 35 3534 3538 I-cancer

systolic 0 8 3539 3547 B-clinical_variable
blood 9 14 3548 3553 I-clinical_variable
pressure 15 23 3554 3562 I-clinical_variable
greater 24 31 3563 3570 O
than 32 36 3571 3575 O
or 37 39 3576 3578 O
equal 40 45 3579 3584 O
to 46 48 3585 3587 O
150 49 52 3588 3591 B-lower_bound

urine 0 5 3592 3597 O
dipstick 6 14 3598 3606 O
for 15 18 3607 3610 O
proteinuria 19 30 3611 3622 B-clinical_variable
greater 31 38 3623 3630 O
than 39 43 3631 3635 O
or 44 46 3636 3638 O
equal 47 52 3639 3644 O
to 53 55 3645 3647 O
2 56 57 3648 3649 B-lower_bound
or 58 60 3650 3652 O
more 61 65 3653 3657 O

